DIMERIX LIMITED - Announcements

6.86%

47.5¢

Market Cap $285.0M

Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

DXB	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	25/07/25	689.15KB	Share
DXB	Change of Director's Interest Notice - SP		07/07/25	201.69KB	Share
DXB	Application for quotation of securities - DXB		01/07/25	395.61KB	Share
DXB	Dimerix receives 1st Development Milestone payment from FUSO	PRICE SENSITIVE	30/06/25	347.49KB	Share
DXB	Application for quotation of securities - DXB		27/06/25	373.71KB	Share
DXB	Application for quotation of securities - DXB		24/06/25	15.62KB	Share
DXB	Change of Director's Interest Notice - SP		23/06/25	202.37KB	Share
DXB	Application for quotation of securities - DXB		19/06/25	15.62KB	Share
DXB	Investor Presentation		19/06/25	1.67MB	Share
DXB	Application for quotation of securities - DXB		17/06/25	15.61KB	Share
DXB	ACTION3 Clinical Trial Milestone Recruitment Update	PRICE SENSITIVE	13/06/25	327.97KB	Share
DXB	Application for quotation of securities - DXB		12/06/25	15.61KB	Share
DXB	Application for quotation of securities - DXB		10/06/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		05/06/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		03/06/25	15.57KB	Share
DXB	1st ACTION3 site in Japan activated and milestone triggered	PRICE SENSITIVE	30/05/25	411.45KB	Share
DXB	Application for quotation of securities - DXB		29/05/25	15.57KB	Share
DXB	Notification of upcoming expiry of Listed Options		29/05/25	1.05MB	Share
DXB	Application for quotation of securities - DXB		27/05/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		22/05/25	15.57KB	Share
DXB	Successful planned IDMC review of ACTION3 trial	PRICE SENSITIVE	22/05/25	314.71KB	Share
DXB	Change in substantial holding		20/05/25	136.45KB	Share
DXB	Application for quotation of securities - DXB		20/05/25	15.57KB	Share
DXB	Dimerix to present at Melbourne Twilight Investor Briefing		20/05/25	3.03MB	Share
DXB	Application for quotation of securities - DXB		16/05/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		14/05/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		12/05/25	15.56KB	Share
DXB	Application for quotation of securities - DXB		08/05/25	15.57KB	Share
DXB	Dimerix receives initial upfront payment from Amicus	PRICE SENSITIVE	06/05/25	325.79KB	Share
DXB	Application for quotation of securities - DXB		01/05/25	15.56KB	Share
DXB	Investor Webinar and Presentation	PRICE SENSITIVE	01/05/25	2.57MB	Share
DXB	Dimerix Licenses DMX-200 in the US	PRICE SENSITIVE	01/05/25	335.92KB	Share
DXB	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	30/04/25	545.42KB	Share
DXB	Trading Halt	PRICE SENSITIVE	29/04/25	434.81KB	Share
DXB	Application for quotation of securities - DXB		28/04/25	15.57KB	Share
DXB	FDA confirms Proteinuria as Primary Endpoint for US approval	PRICE SENSITIVE	28/04/25	359.86KB	Share
DXB	Application for quotation of securities - DXB		22/04/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		16/04/25	15.57KB	Share
DXB	Dimerix to Present at ASX CEO Connect		15/04/25	2.77MB	Share
DXB	Application for quotation of securities - DXB		10/04/25	15.57KB	Share
DXB	Securities Trading Policy Update		08/04/25	503.57KB	Share
DXB	Application for quotation of securities - DXB		04/04/25	15.56KB	Share
DXB	Application for quotation of securities - DXB		02/04/25	15.57KB	Share
DXB	Dimerix to Present at HealthInvest Summit		02/04/25	6.39MB	Share
DXB	Application for quotation of securities - DXB		28/03/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		26/03/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		20/03/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		14/03/25	15.57KB	Share
DXB	Dimerix to Present at Euroz Hartley Institutional Conference		13/03/25	6.93MB	Share
DXB	Application for quotation of securities - DXB		12/03/25	15.57KB	Share
DXB	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
DXB	Application for quotation of securities - DXB		06/03/25	15.56KB	Share
DXB	Dimerix receives initial upfront payment from FUSO	PRICE SENSITIVE	04/03/25	402.28KB	Share
DXB	Application for quotation of securities - DXB		03/03/25	15.57KB	Share
DXB	Investor Presentation		26/02/25	6.36MB	Share
DXB	Half-Year Financial Report & Appendix 4D - 31 December 2024	PRICE SENSITIVE	25/02/25	2.1MB	Share
DXB	Application for quotation of securities - DXB		21/02/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		18/02/25	15.56KB	Share
DXB	Application for quotation of securities - DXB		12/02/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		10/02/25	15.56KB	Share
DXB	Application for quotation of securities - DXB		05/02/25	15.57KB	Share
DXB	Appendix 3Y Correction		05/02/25	425.73KB	Share
DXB	Change of Director's Interest Notice - NW		04/02/25	159.44KB	Share
DXB	Investor Presentation - Euroz Hartley Healthcare Forum		04/02/25	6.95MB	Share
DXB	Application for quotation of securities - DXB		31/01/25	15.57KB	Share
DXB	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	28/01/25	804.33KB	Share
DXB	Application for quotation of securities - DXB		24/01/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		22/01/25	15.57KB	Share
DXB	Application for quotation of securities - DXB		16/01/25	15.57KB	Share
DXB	First Paediatric Patient Recruited for ACTION3	PRICE SENSITIVE	16/01/25	387.81KB	Share
DXB	Application for quotation of securities - DXB		13/01/25	15.57KB	Share
DXB	Investor Presentation		07/01/25	7.1MB	Share
DXB	Dimerix enters Development and License Agreement for Japan	PRICE SENSITIVE	07/01/25	357.12KB	Share
DXB	DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete	PRICE SENSITIVE	30/12/24	350.16KB	Share
DXB	Application for quotation of securities - DXB		16/12/24	15.57KB	Share
DXB	Successful planned IDMC review of ACTION3 trial	PRICE SENSITIVE	20/11/24	258.63KB	Share
DXB	Investor Presentation		18/11/24	5.44MB	Share
DXB	Dimerix Receives $7.9M R&D Tax Incentive Rebate	PRICE SENSITIVE	15/11/24	338.36KB	Share
DXB	Application for quotation of securities - DXB		08/11/24	15.56KB	Share
DXB	Application for quotation of securities - DXB		07/11/24	15.58KB	Share
DXB	Dimerix to Host Technical Webinar on PARASOL FSGS Insights		06/11/24	400.74KB	Share
DXB	NEPTUNE Study Network to Enhance Phase 3 Recruitment in US	PRICE SENSITIVE	01/11/24	369.19KB	Share
DXB	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	31/10/24	498.81KB	Share
DXB	Project PARASOL Update & Medical Advisory Board Appointment	PRICE SENSITIVE	28/10/24	373.43KB	Share
DXB	Change of Director's Interest Notice - CS,HA,NW,SP & MD		25/10/24	389.37KB	Share
DXB	Notification regarding unquoted securities - DXB		22/10/24	16.61KB	Share
DXB	Application for quotation of securities - DXB		15/10/24	15.58KB	Share
DXB	Results of Meeting		01/10/24	300.55KB	Share
DXB	Application for quotation of securities - DXB		01/10/24	15.57KB	Share
DXB	Chair Address and AGM Presentation		01/10/24	3.29MB	Share
DXB	Application for quotation of securities - DXB		17/09/24	15.57KB	Share
DXB	ACTION3 Trial Recruitment and Multiregion Trial Site Update	PRICE SENSITIVE	16/09/24	310.81KB	Share
DXB	Application for quotation of securities - DXB		13/09/24	15.58KB	Share
DXB	First Paediatric Site Activated and Trial Update	PRICE SENSITIVE	12/09/24	321.53KB	Share
DXB	Application for quotation of securities - DXB		11/09/24	15.58KB	Share
DXB	First patient enters into Open Label Extension study	PRICE SENSITIVE	10/09/24	306.9KB	Share
DXB	Letter to Shareholders, Notice of AGM & Proxy Form		02/09/24	895.78KB	Share
DXB	Appendix 4G and Corporate Governance Statement		29/08/24	686.65KB	Share
DXB	Annual Report		29/08/24	3.03MB	Share
DXB	Preliminary Final Report	PRICE SENSITIVE	29/08/24	174.9KB	Share

DXB Quarterly Appendix 4C and Activities Report
25/07/25	PRICE SENSITIVE	689.15KB	Share
DXB Change of Director's Interest Notice - SP
07/07/25		201.69KB	Share
DXB Application for quotation of securities - DXB
01/07/25		395.61KB	Share
DXB Dimerix receives 1st Development Milestone payment from FUSO
30/06/25	PRICE SENSITIVE	347.49KB	Share
DXB Application for quotation of securities - DXB
27/06/25		373.71KB	Share
DXB Application for quotation of securities - DXB
24/06/25		15.62KB	Share
DXB Change of Director's Interest Notice - SP
23/06/25		202.37KB	Share
DXB Application for quotation of securities - DXB
19/06/25		15.62KB	Share
DXB Investor Presentation
19/06/25		1.67MB	Share
DXB Application for quotation of securities - DXB
17/06/25		15.61KB	Share
DXB ACTION3 Clinical Trial Milestone Recruitment Update
13/06/25	PRICE SENSITIVE	327.97KB	Share
DXB Application for quotation of securities - DXB
12/06/25		15.61KB	Share
DXB Application for quotation of securities - DXB
10/06/25		15.57KB	Share
DXB Application for quotation of securities - DXB
05/06/25		15.57KB	Share
DXB Application for quotation of securities - DXB
03/06/25		15.57KB	Share
DXB 1st ACTION3 site in Japan activated and milestone triggered
30/05/25	PRICE SENSITIVE	411.45KB	Share
DXB Application for quotation of securities - DXB
29/05/25		15.57KB	Share
DXB Notification of upcoming expiry of Listed Options
29/05/25		1.05MB	Share
DXB Application for quotation of securities - DXB
27/05/25		15.57KB	Share
DXB Application for quotation of securities - DXB
22/05/25		15.57KB	Share
DXB Successful planned IDMC review of ACTION3 trial
22/05/25	PRICE SENSITIVE	314.71KB	Share
DXB Change in substantial holding
20/05/25		136.45KB	Share
DXB Application for quotation of securities - DXB
20/05/25		15.57KB	Share
DXB Dimerix to present at Melbourne Twilight Investor Briefing
20/05/25		3.03MB	Share
DXB Application for quotation of securities - DXB
16/05/25		15.57KB	Share
DXB Application for quotation of securities - DXB
14/05/25		15.57KB	Share
DXB Application for quotation of securities - DXB
12/05/25		15.56KB	Share
DXB Application for quotation of securities - DXB
08/05/25		15.57KB	Share
DXB Dimerix receives initial upfront payment from Amicus
06/05/25	PRICE SENSITIVE	325.79KB	Share
DXB Application for quotation of securities - DXB
01/05/25		15.56KB	Share
DXB Investor Webinar and Presentation
01/05/25	PRICE SENSITIVE	2.57MB	Share
DXB Dimerix Licenses DMX-200 in the US
01/05/25	PRICE SENSITIVE	335.92KB	Share
DXB Quarterly Appendix 4C and Activities Report
30/04/25	PRICE SENSITIVE	545.42KB	Share
DXB Trading Halt
29/04/25	PRICE SENSITIVE	434.81KB	Share
DXB Application for quotation of securities - DXB
28/04/25		15.57KB	Share
DXB FDA confirms Proteinuria as Primary Endpoint for US approval
28/04/25	PRICE SENSITIVE	359.86KB	Share
DXB Application for quotation of securities - DXB
22/04/25		15.57KB	Share
DXB Application for quotation of securities - DXB
16/04/25		15.57KB	Share
DXB Dimerix to Present at ASX CEO Connect
15/04/25		2.77MB	Share
DXB Application for quotation of securities - DXB
10/04/25		15.57KB	Share
DXB Securities Trading Policy Update
08/04/25		503.57KB	Share
DXB Application for quotation of securities - DXB
04/04/25		15.56KB	Share
DXB Application for quotation of securities - DXB
02/04/25		15.57KB	Share
DXB Dimerix to Present at HealthInvest Summit
02/04/25		6.39MB	Share
DXB Application for quotation of securities - DXB
28/03/25		15.57KB	Share
DXB Application for quotation of securities - DXB
26/03/25		15.57KB	Share
DXB Application for quotation of securities - DXB
20/03/25		15.57KB	Share
DXB Application for quotation of securities - DXB
14/03/25		15.57KB	Share
DXB Dimerix to Present at Euroz Hartley Institutional Conference
13/03/25		6.93MB	Share
DXB Application for quotation of securities - DXB
12/03/25		15.57KB	Share
DXB S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
DXB Application for quotation of securities - DXB
06/03/25		15.56KB	Share
DXB Dimerix receives initial upfront payment from FUSO
04/03/25	PRICE SENSITIVE	402.28KB	Share
DXB Application for quotation of securities - DXB
03/03/25		15.57KB	Share
DXB Investor Presentation
26/02/25		6.36MB	Share
DXB Half-Year Financial Report & Appendix 4D - 31 December 2024
25/02/25	PRICE SENSITIVE	2.1MB	Share
DXB Application for quotation of securities - DXB
21/02/25		15.57KB	Share
DXB Application for quotation of securities - DXB
18/02/25		15.56KB	Share
DXB Application for quotation of securities - DXB
12/02/25		15.57KB	Share
DXB Application for quotation of securities - DXB
10/02/25		15.56KB	Share
DXB Application for quotation of securities - DXB
05/02/25		15.57KB	Share
DXB Appendix 3Y Correction
05/02/25		425.73KB	Share
DXB Change of Director's Interest Notice - NW
04/02/25		159.44KB	Share
DXB Investor Presentation - Euroz Hartley Healthcare Forum
04/02/25		6.95MB	Share
DXB Application for quotation of securities - DXB
31/01/25		15.57KB	Share
DXB Quarterly Appendix 4C and Activities Report
28/01/25	PRICE SENSITIVE	804.33KB	Share
DXB Application for quotation of securities - DXB
24/01/25		15.57KB	Share
DXB Application for quotation of securities - DXB
22/01/25		15.57KB	Share
DXB Application for quotation of securities - DXB
16/01/25		15.57KB	Share
DXB First Paediatric Patient Recruited for ACTION3
16/01/25	PRICE SENSITIVE	387.81KB	Share
DXB Application for quotation of securities - DXB
13/01/25		15.57KB	Share
DXB Investor Presentation
07/01/25		7.1MB	Share
DXB Dimerix enters Development and License Agreement for Japan
07/01/25	PRICE SENSITIVE	357.12KB	Share
DXB DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete
30/12/24	PRICE SENSITIVE	350.16KB	Share
DXB Application for quotation of securities - DXB
16/12/24		15.57KB	Share
DXB Successful planned IDMC review of ACTION3 trial
20/11/24	PRICE SENSITIVE	258.63KB	Share
DXB Investor Presentation
18/11/24		5.44MB	Share
DXB Dimerix Receives $7.9M R&D Tax Incentive Rebate
15/11/24	PRICE SENSITIVE	338.36KB	Share
DXB Application for quotation of securities - DXB
08/11/24		15.56KB	Share
DXB Application for quotation of securities - DXB
07/11/24		15.58KB	Share
DXB Dimerix to Host Technical Webinar on PARASOL FSGS Insights
06/11/24		400.74KB	Share
DXB NEPTUNE Study Network to Enhance Phase 3 Recruitment in US
01/11/24	PRICE SENSITIVE	369.19KB	Share
DXB Quarterly Appendix 4C and Activities Report
31/10/24	PRICE SENSITIVE	498.81KB	Share
DXB Project PARASOL Update & Medical Advisory Board Appointment
28/10/24	PRICE SENSITIVE	373.43KB	Share
DXB Change of Director's Interest Notice - CS,HA,NW,SP & MD
25/10/24		389.37KB	Share
DXB Notification regarding unquoted securities - DXB
22/10/24		16.61KB	Share
DXB Application for quotation of securities - DXB
15/10/24		15.58KB	Share
DXB Results of Meeting
01/10/24		300.55KB	Share
DXB Application for quotation of securities - DXB
01/10/24		15.57KB	Share
DXB Chair Address and AGM Presentation
01/10/24		3.29MB	Share
DXB Application for quotation of securities - DXB
17/09/24		15.57KB	Share
DXB ACTION3 Trial Recruitment and Multiregion Trial Site Update
16/09/24	PRICE SENSITIVE	310.81KB	Share
DXB Application for quotation of securities - DXB
13/09/24		15.58KB	Share
DXB First Paediatric Site Activated and Trial Update
12/09/24	PRICE SENSITIVE	321.53KB	Share
DXB Application for quotation of securities - DXB
11/09/24		15.58KB	Share
DXB First patient enters into Open Label Extension study
10/09/24	PRICE SENSITIVE	306.9KB	Share
DXB Letter to Shareholders, Notice of AGM & Proxy Form
02/09/24		895.78KB	Share
DXB Appendix 4G and Corporate Governance Statement
29/08/24		686.65KB	Share
DXB Annual Report
29/08/24		3.03MB	Share
DXB Preliminary Final Report
29/08/24	PRICE SENSITIVE	174.9KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 47.5¢		Change -0.035(6.86%)		Mkt cap ! $285.0M

Open	High	Low	Value	Volume
51.0¢	51.0¢	47.5¢	$1.682M	3.440M

Buyers (Bids)

No.	Vol.	Price($)
6	73129	47.5¢

Sellers (Offers)

Price($)	Vol.	No.
48.0¢	91753	1

View Market Depth

No.	Vol.	Price($)
6	73129	0.475
2	40000	0.470
5	111012	0.465
7	31339	0.460
2	20000	0.455

Price($)	Vol.	No.
0.480	91753	1
0.485	24343	3
0.490	31025	1
0.495	26800	2
0.500	42688	3

Last trade - 16.10pm 30/07/2025 (20 minute delay)


Last 48.0¢		Change -0.035 ( 4.29 %)
Open	High	Low	Volume
51.0¢	51.0¢	47.5¢	1488932
Last updated 15.58pm 30/07/2025 ?

DXB (ASX) Chart

DIMERIX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories